Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2019

Open Access 01.12.2019 | Research

Bacterial colonization of seromas after breast cancer surgery with and without local steroid prophylaxis

verfasst von: Christen Kirk Axelsson, Gro Maria Qvamme, Mette Okholm, Charlotte Lanng, Magnus Arpi, Minea Bruusgaard Mortensen, Birgitte Wegeberg, Pal Bela Szecsi

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2019

Abstract

Background

Seroma formation is a frequent postoperative sequela after mastectomy for primary breast cancer. We investigated the role of bacterial colonization of seroma fluid with three different culture methods and the effect of intracavitary steroids.

Methods

The study group consisted of 212 patients scheduled for mastectomy from a previously performed double-blind randomized placebo-controlled intervention trial. The patients were allocated to a single dose of 80 mg of steroids (methylprednisolone) or saline, and the effect on seroma formation was investigated. From each aspiration, an equal volume of seroma fluid (10 mL) was distributed into one sterile transport tube (conventional method), one aerobic blood culture bottle and one anaerobic blood culture bottle.

Results

There was significant variation in the number of bacterial species detected in seroma samples among the three culture methods, ranging from 18 species with the conventional culture tubes to 40 species with aerobic blood culture bottles. Patients receiving prophylactic steroids had significantly more frequent colonization than those in the saline group. Nevertheless, the clinical surgical site infection rate of 7.0% was equal between the two groups.

Conclusions

In general, data analysis of the entire set of case material did not succeed in demonstrating a relationship between a specific bacterial species or a combination of species and seroma formation. However, in the few patients with growth of a pathogenic species, both the duration of seroma formation and volume of seroma fluid were more pronounced.
Trial registration: Ethics Committee of Copenhagen (H-4-2009-137), (EudraCT number 2009-016650-40), the Danish Data Protection Agency (code J. no. F.750.75-2), and the Danish Health and Medicines Authority (sponsor protocol code number 23837). Start date November 2010.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ANOVA
Analysis of variance
CI
Confidence interval
MALDI-TOF
Matrix-assisted laser desorption/ionization—time of flight
OR
Odds ratio
RR
Pooled risk ratio
SSI
Surgical site infection

Background

Seroma formation is the most prevalent complication after mastectomy and axillary lymph node dissection and is often regarded as an unavoidable nuisance rather than a serious complication [1, 2]. However, seromas result in patient discomfort and repeated hospital visits and may delay adjuvant therapy.
Seroma formation has an acute inflammatory component in response to surgical trauma [3, 4] via the activities of proteinases, proteinase inhibitors, cytokines, and growth factors [5, 6]. In the early postoperative period, seroma fluid slowly becomes exudative with some characteristics similar to those of lymph [7]. Decreasing the inflammatory response with steroids has been successfully performed for major abdominal surgery [8], colonic resection [9], head and neck surgery [10], plastic surgery [11], and cardiac surgery [12]. Local administration of the steroid triamcinolone into the wound cavity after autologous latissimus dorsi breast reconstruction has been shown to reduce seroma formation [13], whereas a single intravenous bolus of steroids (methylprednisolone) before mastectomy exerted no effect [14]. Steroid administration into the wound cavity on the first day after mastectomy with sentinel lymph node biopsy exerted a significant preventive effect against seroma formation during the next 30 days, while no effect was observed after mastectomy with axillary lymph node dissection [15].
This study evaluates the hypothesis that subclinical bacterial colonization is a contributing pathogenic factor to seroma formation after mastectomy with axillary lymph node dissection and evaluates whether steroid prophylaxis increases the risk of subclinical infection. Furthermore, we investigated whether repeated seroma punctures introduce opportunistic subclinical infection, contributing to persistence of seromas.

Materials and methods

Study group

This observational study was a part of a double-blind randomized placebo-controlled intervention study described in detail previously [15, 16]. Briefly, the original study (EudraCT number 2009-016650-40) analyzed the effect on seroma formation after mastectomy of a single dose of 80 mg of steroids into the mastectomy cavity. A total of 212 patients were randomized. The per-protocol study group consisted of 100 patients in the saline group and 99 patients in the steroid group. The study demonstrated that injection of methylprednisolone acetate on the first day after mastectomy and sentinel node biopsy had a significant effect on the prevention of seroma formation. Steroid administration more than halved the number of patients who did develop a seroma, reduced the number of aspirations required, and decreased the mean and cumulative seroma volume within both 10 and 30 days. The effect of steroid was not seen in the mastectomy and axillary level 1–2 dissection group.

Microbiological examination

Seroma puncture was performed in a sterile closed system. One aerobic and one anaerobic blood culture bottle (BACTECTM, Becton Dickinson, Franklin Lakes, NJ, USA) were each inoculated with 10 mL of seroma fluid immediately after collection and an additional 10 mL were collected in a sterile transport tube (conventional method). The samples were transported to the Department of Clinical Microbiology as fast as possible, and kept at room temperature (bottles) or at 4 °C (transport tube) until arrival. At arrival, the seroma fluid in the transport tube was cultured on a 5% blood agar plate and a chocolate plate (Oxoid, Basingstoke, Hampshire, UK). Plates were examined after incubation for 1 and 2 days at 35 °C and 5% CO2. Aerobic and anaerobic blood culture bottles were incubated for 5 days in the BACTECTM instrument. When the instrument indicated positivity, the bottle was subcultured on the same plates as the specimen in the transport tube. All isolates were identified to the species level with matrix-assisted laser desorption/ionization–time of flight (MALDI-TOF; Bruker Daltonics, Billerica, MA, USA).
Staphylococcus aureus, β-hemolytic streptococci, Enterobacteriaceae, and Pseudomonas aeruginosa were considered likely pathogenic bacteria. Common skin commensal bacteria (e.g., coagulase-negative staphylococci (except for Staphylococcus lugdunensis), Micrococcus species, Corynebacterium species, Propionibacterium species) were regarded as contaminants, except when the same species was isolated in two time-separated cultures within a 5-day period [17]. Quantitative culture of seroma fluid from the transport tube was not performed. The culture results from the research specimens were concealed from the clinicians until the end of the study unless a clinical surgical site infection (SSI) occurred and in a single patient with growth of P. aeruginosa. The use of antibiotics was solely a clinical decision based on the presence of a combination of fever, redness of the wound, and/or purulent seroma fluid.

Statistics

Groups were compared using one-way analysis of variance (ANOVA). Levene’s test for homogeneity of variance, and post hoc analyses with Tamhane’s T2, assuming unequal variances and group sizes, were used to investigate the nature of any differences. Associations of categorical factors were analyzed using the chi-square test or Fisher’s exact test and calculation of odds ratios (ORs) and 95% confidence intervals (CIs). A two-tailed value of p < 0.05 was considered statistically significant. Data analyses were performed using SPSS software Version 22.0 (IBM, Armonk, NY, USA).

Results

Study demography

During the study period, 881 seroma aspirations (439 in the saline group and 442 in the steroid treatment group) were evaluated by microbial culture. These aspirations were performed in 141 patients (82 patients in the saline group and 59 in the steroid treatment group). On average, each of these patients had a seroma aspirated 8 times (range, 1–51 times), including 8.4 times in the saline and 7.6 times in the steroid group. The findings during the entire study period from the examination of 2643 seroma cultures distributed among the three culture methods are presented in Table 1.
Table 1
Microbiologic findings in all 881 seroma samples after primary breast cancer surgery in 199 patients expressed as a percentage of positive and negative cultures in the groups treated with steroids (methylprednisolone) or saline. Microorganisms in seroma cultures were identified with a conventional method and with aerobic and anaerobic blood culture bottles. The results of each of the culture methods (counts and percentages) are shown in relation to the combined evaluation of all three methods and classified according to the microbiological finding and treatment group. Data were not available in some cases for all three microbiological methods. The present study was part of a double-blind randomized placebo-controlled intervention study that analyzed the effect of a single dose of 80 mg of steroids on seroma formation after mastectomy
 
Culture method
 
Conventional methoda
Aerobic blood culture bottleb
Anaerobic blood culture bottlec
Treatment
Neg
n = 746
n (%)
Pos
n = 131
n (%)
Neg
n = 645
n (%)
Pos
n = 230
n (%)
Neg
n = 656
n (%)
Pos
n = 214
n (%)
Saline
406 (46.1)
31 (3.5)
363 (41.2)
73 (8.3)
368 (41.8)
65 (7.4)
Steroids
340 (38.6)
100 (11.4)*
282 (32.0)
157 (17.8)*
288 (32.7)
149 (16.9)*
Saline vs steroids odds ratio
(95% CI)
6.58
(3.82–11.34)
5.02
(3.30–7.62)
4.74
(3.11–7.24)
aData not available in 4 cases (0.5%)
bData not available in 6 cases (0.7%)
cData not available in 11 cases (1.2%)
*Positive culture steroids vs saline, Fisher’s exact test p < 0.001

Surgical si te infection (SSI)

Seven patients in both the steroid and saline groups were treated with antibiotics due to a surgical site infection SSI during the first 30 days postoperatively. The median time of occurrence of a SSI was on the 15th day (range, 3–23 days) postoperatively in the saline group and on the 17th day (range, 11–24 days) postoperatively in the steroid group. SSIs occurred after more than 30 days postoperatively in six patients in the saline group after 8–36 aspirations after 33–110 days postoperatively. In the steroid group, SSIs occurred in 11 patients after 5–24 aspirations after 41–153 days postoperatively. Among these patients, two patients had reinfections, including one patient in the saline group at 70 days postoperatively and one patient in the steroid group at 85 days postoperatively. All patients recovered following antibiotic treatment. No differences in the frequency of SSIs between the saline and steroid groups before or after 30 days postoperatively were observed.

Culture methods

The findings by the three culture methods are presented in Table 1. Data were not available in four cases (0.5%) from the conventional culture method, in 6 cases (0.7%) from aerobic blood culture bottles and in 11 cases (1.2%) from anaerobic blood culture bottles. The conventional culture method resulted in a significantly lower detection rate than both aerobic blood culture bottles and anaerobic blood culture bottles (Fisher's exact test p < 0.0001) (data not shown). No significant differences in the detection rate between aerobic and anaerobic blood culture bottles were observed.

Effect of steroid

Steroid treatment resulted in significantly more positive seroma cultures than saline as assessed by the conventional method (p < 0.0001, OR 6.58, 95% CI 3.82–11.34), aerobic blood culture bottles (p < 0.0001, OR 5.02, 95% CI 3.30–7.62), and anaerobic blood culture bottles (p < 0.0001, OR 4.74, 95% CI 3.11–7.24) (Table 1). Among the 532 seroma aspirations (300 in the saline group and 232 in the steroid group), that occurred within the first 30 days after surgery, 63 aspirations (11.8%) and 118 aspirations (22.2%) in the saline and steroid groups, respectively, were positive with at least one of the three culture methods. Positive cultures occurred significantly more frequently in the steroid treatment group (Fisher's exact test p < 0.0001, OR 3.90, 95% CI 2.66–5.69).

Microbiological colonization

The spectrum of bacterial species varied among the three culture methods (Table 2). The number of bacterial species in monomicrobial and polymicrobial cultures ranged from a minimum of 18 (conventional culture) to 32 (anaerobic blood culture bottle) to a maximum of 40 species (aerobic blood culture bottle), among which S. epidermidis was found in nearly half of all positive cultures. There was a similar species distribution in the steroid and saline groups, but there was a higher frequency in the steroid group (p < 0.0001); S. epidermidis was again the dominant species identified in nearly half of the positive cultures. Employing aerobic and anaerobic blood culture bottles increased the identification rates of staphylococci and streptococci with a factor of two to three. S. aureus was the next most frequently identified pathogen, and both species were observed three times more frequently in the steroid group than in the saline group.
Table 2
Species distribution of microorganisms in seroma cultures performed with a conventional method and with aerobic and anaerobic blood culture bottles. Microbiologic findings in 881 seroma samples after primary breast cancer surgery in 199 patients. The present study was part of a double-blind randomized placebo-controlled intervention study that analyzed the effect of a single dose of 80 mg of steroids on seroma formation after mastectomy
Organism
Conventional method
Aerobic blood culture bottle
Anaerobic blood culture bottle
Treatment
Saline
Steroids
Saline
Steroids
Saline
Steroids
No growth (n)
408
340
363
283
368
288
Not performed (n)
1
3
2
4
3
2
Positive culture (n)
30
100
74
156
66
149
Isolates (n)
31
102
78
162
69
154
Staphylococcus aureus
5
17
6
19
6
21
Coagulase-negative staphylococci
 - Staphylococcus epidermidis
 - Staphylococcus lugdunensis
18
13
1
74
48
1
51
29
4
115
68
3
46
31
2
113
70
1
Micrococcus spp.
0
0
4
1
0
0
Rothia spp.
0
0
1
1
1
0
β-hemolytic streptococci
2
3
2
3
2
2
Non-hemolytic streptococci
0
2
4
10
7
9
Corynebacterium spp.
0
1
1
7
0
0
Bacillus spp.
0
2
3
2
1
1
Lactobacillus sp.
0
0
0
0
0
1
Enterobacter cloacae
0
2
0
1
0
3
Pseudomonas spp.
1
0
4
2
4
1
Acinetobacter sp.
0
0
1
0
0
0
Anaerobes
4
1
1
1
2
3

Colonization over time

The rate of positive cultures was constant in both treatment groups up until approximately the tenth day after surgery. After this time, a decrease in the positive culture rate occurred in the saline group, while the initial rate continued to increase in the steroid group until approximately the twenty-fifth day, (ANOVA‚ steroid vs. saline, p = 0.002, Fig. 1). Similarly, the cumulative aspirated volume of seromas with positive cultures was equal in both groups until the twelfth day. After this time, a decrease in cumulative volume occurred in the saline group, while the initial rate continued to increase in the steroid group.
A group of 48 patients with positive cultures and without SSIs or the need for antibiotic treatment underwent aspiration 99 times. They were followed for a median of 16 days (range, 2–57 days) with a median of three aspirations (range, 1–9 positive aspirations) before seroma formation ceased. S. epidermidis was identified in 19 patients, other coagulase-negative staphylococci were identified in 14 patients, and Corynebacterium species were identified in five patients. In the remaining ten patients, miscellaneous species were identified.
All culture results were classified according to probable clinical significance, i.e., contaminant microorganism vs. potentially pathogenic microorganism. A significant difference between the two treatment groups of patients was demonstrated. In the saline group, a higher frequency of contaminant isolates was found. Conversely, in the steroid group, a higher frequency of potentially pathogenic isolates was found (p < 0.001, Table 3). No significant differences in the seroma duration, total cumulative seroma volume, or cumulative seroma volume in the first 10 or 30 days after surgery were observed (p = 0.5) between women with negative cultures and those with any positive cultures (pathogenic or contaminant isolates). However, compared to women with negative cultures (n = 125), women with growth of pathogenic bacteria (n = 59) had a significantly longer seroma duration (42.7 days, p = 0.013), larger total cumulative seroma volume (2255 mL, p = 0.004), and a larger cumulative seroma volume in the first 10 days (185 mL, p = 0.004) or 30 days (983 mL, p = 0.000) after surgery.
Table 3
Microorganisms in seroma cultures performed with a conventional method and with aerobic and anaerobic blood culture bottles. Each positive seroma culture was classified according to the microbiological finding as “most likely irrelevant” (no growth or contamination) or as “most likely pathogenic” (potentially pathogenic or pathogenic). The present study was part of a double-blind randomized placebo-controlled intervention study that analyzed the effect of a single dose of 80 mg of steroids on seroma formation after mastectomy
 
Culture results
 
Bacterial classification
Treatment
Contaminant microorganism n (%)
Most likely pathogenic microorganism n (%)
Saline
254 (49.0%)
39 (7.5%)
Steroids
213 (5.1%)
95 (18.3%)*
Saline vs steroids odds ratio
(95% CI)
4.76
(3.10–7.31)
*Significant more “probably pathogenic” growth occurred in the steroid group (Fisher’s exact test p < 0.001).

Discussion

Through the decades, seroma formation after breast surgery has been a topic of discussion. Most papers have focused on how to avoid or how to treat seromas [18, 19]. The microbiological spectrum and subclinical bacterial colonization as risk factors for seroma formation have not gained much attention. The present study is one of few studies to present a systematic and longitudinal study of the microbiological spectrum present in seromas after breast surgery [20]. Three different culture methods were investigated, and a variation in species was detected. The aerobic and anaerobic blood culture methods revealed a wide spectrum of species compared with the conventional culture method (Table 2). The increased number of different species observed with both aerobic and anaerobic blood culture bottles is of scientific interest, but this finding goes beyond daily clinical routines. The finding that the overall frequency of negative cultures evenly declined from the first puncture to the approximately 45th puncture in individual patients is in accordance with the theory that seromas are associated with a slowly declining inflammatory reaction. The finding that the rate of positive cultures was nearly constant during the first 50 days indicates that perioperative subclinical colonization occurs despite aseptic technique. However, during the first 30 days after surgery, the rate of seroma aspirations with microbial growth was noticeably lower after the 12th day postoperatively in the saline group than in the steroid group (Fig. 1). Similarly, the seroma volume decreased in the saline group after the 10th day. This finding indicates that steroid treatment has some adverse effects on seroma formation among the patients with positive cultures, even though this effect was not observed during the first 10–12 days or in the overall population. However, the follow-up of the group of 48 patients with positive seroma cultures but normal clinical findings and the presence of potential pathogenic bacteria showed that seroma formation decreased spontaneously. This result indicates that culture-positive findings alone are not an automatic indication for antibiotic treatment. The dominant microbiological species identified in the present study were S. epidermidis and S. aureus. While nosocomial infections with S. epidermidis have gained much attention, it has been suggested that this skin colonizer has apparently not evolved to cause disease but maintains a benign relationship with its host [21]. S. epidermidis is generally associated with catheters and other medical implants. With such characteristics, S. epidermidis could be hypothesized to be a possible provoking factor for seroma formation. This study did not confirm this hypothesis, and these bacteria were only involved in two cases of SSIs.
The association between women with negative cultures compared to positive cultures with pathogenic isolates could support a causal factor on seroma production. However, the finding is based on small numbers of cultivations so conclusions cannot be drawn, and furthermore it is likely that the more frequent and longer seroma formation has a higher risk for having pathogenic bacteria introduced.
In planning the study, the use of steroids was hypothesized to be a risk factor for infection, and our results confirmed that colonization of seromas in the steroid group was more frequent. Frequent colonization was also observed in the saline group, but to a lesser degree. However, notably, only 14 of 199 patients (7.0%) developed SSIs within the first 30 days after surgery (the maximal duration of steroid action), with no overrepresentation in the steroid group. The patients were only treated with antibiotics on a clinical basis. The incidence of SSIs in breast cancer surgery is reported to range between 3% [22] and 15% [23, 24]. The present finding of a 7% incidence of SSIs is higher than the reported 3.4% rate associated with clean surgical techniques [25]. However, the use of prophylactic antibiotics to prevent infection is still a controversial issue, and routine use is not common in breast cancer surgery. Suboptimal prophylactic antibiotics may increase the risk of infection [26]. A large series of reduction mammoplasty recommended a single intravenous perioperative dose of antibiotics with action against S. aureus [24]. In 2014, a Cochrane review of 11 studies (2867 participants) demonstrated that prophylactic antibiotics administered preoperatively significantly reduced the incidence of SSIs among patients undergoing breast cancer surgery without reconstruction (pooled risk ratio (RR) 0.67, 95% CI 0.53–0.85) [23]. A short Cochrane review of a single study comparing perioperative antibiotics with no antibiotics found no statistically significant effect of antibiotics on the incidence of SSIs (RR 0.11, 95% CI 0.01–1.95) [27]. A recent Australian retrospective cross-sectional study reported a growing adherence to surgical antibiotic prophylaxis guidelines in breast surgery and concluded that the incidence of SSIs was low, and there was no relationship with adherence to the guidelines [28], indicating that prophylaxis was effective [14]. In contrast, the present study indicates that antibiotic treatment, based solely on clinical observations, was effective and safe. Had our study been based on culture results, we estimate that two or three as many patients would have received redundant antibiotic treatment. Our results from present and earlier studies [1416] combined with other results [13] led to recommendations for seroma prophylaxis with intracavitary steroids with optional repeated steroid administration if the seroma persists.

Conclusions

In summary, our data analysis on the case material did not succeed in demonstrating a relationship between a specific bacterial species or combination of species and seroma formation. Instillation of steroids on the first postoperative day resulted in frequent colonization with various species compared with instillation of saline. These findings do not support any routine culture schedule for every seroma sample or the necessity of prophylactic antibiotic treatment due to seroma prophylaxis with steroids. Empirical clinical evaluation of the indications for antibiotic treatment for infected seromas was sufficient and safe.

Acknowledgements

The authors thank the participating patients for their conscientious cooperation and the entire staff of the participating departments for their expert assistance.
This study was approved by the local Ethics Committee and informed consent was obtained from all participants.
Not applicable.

Competing interests

The authors declares that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol. 2011;37:829–35.CrossRef van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol. 2011;37:829–35.CrossRef
2.
Zurück zum Zitat Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK. Seroma formation following breast cancer surgery. Breast J. 2003;9:385–8.CrossRef Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK. Seroma formation following breast cancer surgery. Breast J. 2003;9:385–8.CrossRef
3.
Zurück zum Zitat Watt-Boolsen S, Nielsen VB, Jensen J, Bak S. Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. Dan Med Bull. 1989;36:487–9.PubMed Watt-Boolsen S, Nielsen VB, Jensen J, Bak S. Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. Dan Med Bull. 1989;36:487–9.PubMed
4.
Zurück zum Zitat McCaul JA, Aslaam A, Spooner RJ, Louden I, Cavanagh T, Purushotham AD. Aetiology of seroma formation in patients undergoing surgery for breast cancer. The Breast. 2000;9:144–8.CrossRef McCaul JA, Aslaam A, Spooner RJ, Louden I, Cavanagh T, Purushotham AD. Aetiology of seroma formation in patients undergoing surgery for breast cancer. The Breast. 2000;9:144–8.CrossRef
5.
Zurück zum Zitat Baker EA, El-Gaddal S, Williams L, Leaper DJ. Profiles of inflammatory cytokines following colorectal surgery: relationship with wound healing and outcome. Wound Repair Regen. 2006;14:566–72.CrossRef Baker EA, El-Gaddal S, Williams L, Leaper DJ. Profiles of inflammatory cytokines following colorectal surgery: relationship with wound healing and outcome. Wound Repair Regen. 2006;14:566–72.CrossRef
6.
Zurück zum Zitat Szecsi PB, Larsen J, Hørby J, Axelsson CK. Seroma Production After Breast Cancer Surgery has a Pro-Inflammatory Component. Open Breast Cancer J. 2012;4:11–7.CrossRef Szecsi PB, Larsen J, Hørby J, Axelsson CK. Seroma Production After Breast Cancer Surgery has a Pro-Inflammatory Component. Open Breast Cancer J. 2012;4:11–7.CrossRef
7.
Zurück zum Zitat Andrades P, Prado A. Composition of postabdominoplasty seroma. Aesthetic Plast Surg. 2007;31:514–8.CrossRef Andrades P, Prado A. Composition of postabdominoplasty seroma. Aesthetic Plast Surg. 2007;31:514–8.CrossRef
8.
Zurück zum Zitat Srinivasa S, Kahokehr AA, Yu TC, Hill AG. Preoperative glucocorticoid use in major abdominal surgery: systematic review and meta-analysis of randomized trials. Ann Surg. 2011;254:183–91.CrossRef Srinivasa S, Kahokehr AA, Yu TC, Hill AG. Preoperative glucocorticoid use in major abdominal surgery: systematic review and meta-analysis of randomized trials. Ann Surg. 2011;254:183–91.CrossRef
9.
Zurück zum Zitat Schulze S, Andersen J, Overgaard H, Norgard P, Nielsen HJ, Aasen A, Gottrup F, Kehlet H. Effect of prednisolone on the systemic response and wound healing after colonic surgery. Arch Surg. 1997;132:129–35.CrossRef Schulze S, Andersen J, Overgaard H, Norgard P, Nielsen HJ, Aasen A, Gottrup F, Kehlet H. Effect of prednisolone on the systemic response and wound healing after colonic surgery. Arch Surg. 1997;132:129–35.CrossRef
10.
Zurück zum Zitat Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002;195:694–712.CrossRef Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002;195:694–712.CrossRef
11.
Zurück zum Zitat Berberich T, Haecker FM, Kehrer B, Erb TO, Gunthard J, Hammer J, Jenny PM. Postpericardiotomy syndrome after minimally invasive repair of pectus excavatum. J Pediatr Surg. 2004;39:e1–3.CrossRef Berberich T, Haecker FM, Kehrer B, Erb TO, Gunthard J, Hammer J, Jenny PM. Postpericardiotomy syndrome after minimally invasive repair of pectus excavatum. J Pediatr Surg. 2004;39:e1–3.CrossRef
12.
Zurück zum Zitat Park GM, Lee JY, Kim YG, Boo SJ, Song JM, Kang DH, Song JK. Recurrent postoperative effusive-constrictive pericarditis associated with steroid discontinuation. J Cardiovasc Ultrasound. 2009;17:102–5.CrossRef Park GM, Lee JY, Kim YG, Boo SJ, Song JM, Kang DH, Song JK. Recurrent postoperative effusive-constrictive pericarditis associated with steroid discontinuation. J Cardiovasc Ultrasound. 2009;17:102–5.CrossRef
13.
Zurück zum Zitat Taghizadeh R, Shoaib T, Hart AM, Weiler-Mithoff EM. Triamcinolone reduces seroma re-accumulation in the extended latissimus dorsi donor site. J Plast Reconstr Aesthet Surg. 2008;61:636–42.CrossRef Taghizadeh R, Shoaib T, Hart AM, Weiler-Mithoff EM. Triamcinolone reduces seroma re-accumulation in the extended latissimus dorsi donor site. J Plast Reconstr Aesthet Surg. 2008;61:636–42.CrossRef
14.
Zurück zum Zitat Okholm M, Axelsson CK. No effect of steroids on seroma formation after mastectomy. Dan Med Bull. 2011;58:A4241.PubMed Okholm M, Axelsson CK. No effect of steroids on seroma formation after mastectomy. Dan Med Bull. 2011;58:A4241.PubMed
15.
Zurück zum Zitat Qvamme G, Axelsson CK, Lanng C, Mortensen M, Wegeberg B, Okholm M, Arpi MR, Szecsi PB. Randomized clinical trial of prevention of seroma formation after mastectomy by local methylprednisolone injection. Br J Surg. 2015;102:1195–203.CrossRef Qvamme G, Axelsson CK, Lanng C, Mortensen M, Wegeberg B, Okholm M, Arpi MR, Szecsi PB. Randomized clinical trial of prevention of seroma formation after mastectomy by local methylprednisolone injection. Br J Surg. 2015;102:1195–203.CrossRef
16.
Zurück zum Zitat Axelsson CK, Quamme GM, Lanng C, Szecsi PB, Mortensen MB, Wegeberg B, Arpi M, Lingskov M, Puglich MS, Okholm M. Local injection of methylprednisolonacetat to prevent seroma formation after mastectomy. Dan Med J. 2012;59:A4482.PubMed Axelsson CK, Quamme GM, Lanng C, Szecsi PB, Mortensen MB, Wegeberg B, Arpi M, Lingskov M, Puglich MS, Okholm M. Local injection of methylprednisolonacetat to prevent seroma formation after mastectomy. Dan Med J. 2012;59:A4482.PubMed
17.
Zurück zum Zitat Gradel KO, Andersen J, Madsen M. Comparisons of sampling procedures and time of sampling for the detection of Salmonella in Danish infected chicken flocks raised in floor systems. Acta Vet Scand. 2002;43:21–30.CrossRef Gradel KO, Andersen J, Madsen M. Comparisons of sampling procedures and time of sampling for the detection of Salmonella in Danish infected chicken flocks raised in floor systems. Acta Vet Scand. 2002;43:21–30.CrossRef
18.
Zurück zum Zitat Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S. Pathophysiology of seroma in breast cancer. Breast Cancer. 2005;12:288–93.CrossRef Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S. Pathophysiology of seroma in breast cancer. Breast Cancer. 2005;12:288–93.CrossRef
19.
Zurück zum Zitat Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S. Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol. 2006;36:197–206.CrossRef Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S. Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol. 2006;36:197–206.CrossRef
20.
Zurück zum Zitat Felippe WA, Werneck GL, Santoro-Lopes G. Surgical site infection among women discharged with a drain in situ after breast cancer surgery. World J Surg. 2007;31:2293–9.CrossRef Felippe WA, Werneck GL, Santoro-Lopes G. Surgical site infection among women discharged with a drain in situ after breast cancer surgery. World J Surg. 2007;31:2293–9.CrossRef
21.
Zurück zum Zitat Otto M. Staphylococcus epidermidis--the 'accidental' pathogen. Nat Rev Microbiol. 2009;7:555–67.CrossRef Otto M. Staphylococcus epidermidis--the 'accidental' pathogen. Nat Rev Microbiol. 2009;7:555–67.CrossRef
22.
Zurück zum Zitat Lefebvre D, Penel N, Deberles MF, Fournier C. Incidence and surgical wound infection risk factors in breast cancer surgery. Presse Med. 2000;29:1927–32.PubMed Lefebvre D, Penel N, Deberles MF, Fournier C. Incidence and surgical wound infection risk factors in breast cancer surgery. Presse Med. 2000;29:1927–32.PubMed
23.
Zurück zum Zitat Jones DJ, Bunn F, Bell-Syer SV. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev. 2014:CD005360. Jones DJ, Bunn F, Bell-Syer SV. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev. 2014:CD005360.
24.
Zurück zum Zitat Witt A, Yavuz D, Walchetseder C, Strohmer H, Kubista E. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol. 2003;101:745–50.PubMed Witt A, Yavuz D, Walchetseder C, Strohmer H, Kubista E. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol. 2003;101:745–50.PubMed
25.
Zurück zum Zitat Vazquez-Aragon P, Lizan-Garcia M, Cascales-Sanchez P, Villar-Canovas MT, Garcia-Olmo D. Nosocomial infection and related risk factors in a general surgery service: a prospective study. J Infect. 2003;46:17–22.CrossRef Vazquez-Aragon P, Lizan-Garcia M, Cascales-Sanchez P, Villar-Canovas MT, Garcia-Olmo D. Nosocomial infection and related risk factors in a general surgery service: a prospective study. J Infect. 2003;46:17–22.CrossRef
26.
Zurück zum Zitat Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J, Fraser VJ. Risk factors for surgical site infection after major breast operation. J Am Coll Surg. 2008;207:326–35.CrossRef Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J, Fraser VJ. Risk factors for surgical site infection after major breast operation. J Am Coll Surg. 2008;207:326–35.CrossRef
27.
Zurück zum Zitat Blanchard D. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Clin J Oncol Nurs. 2015;19:629–30.CrossRef Blanchard D. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Clin J Oncol Nurs. 2015;19:629–30.CrossRef
28.
Zurück zum Zitat Lavers A, Yip WS, Sunderland B, Parsons R, Mackenzie S, Seet J, Czarniak P. Surgical antibiotic prophylaxis use and infection prevalence in non-cosmetic breast surgery procedures at a tertiary hospital in Western Australia-a retrospective study. PeerJ. 2018;6:e5724.CrossRef Lavers A, Yip WS, Sunderland B, Parsons R, Mackenzie S, Seet J, Czarniak P. Surgical antibiotic prophylaxis use and infection prevalence in non-cosmetic breast surgery procedures at a tertiary hospital in Western Australia-a retrospective study. PeerJ. 2018;6:e5724.CrossRef
Metadaten
Titel
Bacterial colonization of seromas after breast cancer surgery with and without local steroid prophylaxis
verfasst von
Christen Kirk Axelsson
Gro Maria Qvamme
Mette Okholm
Charlotte Lanng
Magnus Arpi
Minea Bruusgaard Mortensen
Birgitte Wegeberg
Pal Bela Szecsi
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2019
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1661-1

Weitere Artikel der Ausgabe 1/2019

World Journal of Surgical Oncology 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.